Suchergebnisse - "Khajavirad, Nasim"

PubPharm (30)

1

Safety and immunogenicity of COReNAPCIN^®, a SARS-CoV-2 mRNA vaccine; a randomized, double-blind, placebo-controlled phase 1 clinical trial

enthalten in: bioRxiv.org | 2023

von Salehi, M. | Darazam, I. | Nematollahi, A. | +12

2

Hemolysis and acquired methemoglobinemia associated with lidocaine and benzocaine topical application : a case report

enthalten in: Journal of medical case reports | 2023

von Khajavirad, N. | Daftari, G. | Jelodar, M.

3

Hemolysis and acquired methemoglobinemia associated with lidocaine and benzocaine topical application: a case report

enthalten in: Journal of medical case reports | 2023

von Khajavirad, N. | Daftari, G. | Jelodar, M.

4

Hemolysis and acquired methemoglobinemia associated with lidocaine and benzocaine topical application: a case report

enthalten in: Journal of medical case reports | 2023

von Khajavirad, N. | Daftari, G. | Jelodar, M.

5

Development and validation of conflict management attitude questionnaire for medical students

enthalten in: BMC medical education | 2022

von Mohseni, F. | Mohammadi, A. | Mafinejad, M. | +2

6

Development and validation of conflict management attitude questionnaire for medical students

enthalten in: BMC medical education | 2022

von Mohseni, F. | Mohammadi, A. | Mafinejad, M. | +2

7

Development and validation of conflict management attitude questionnaire for medical students

enthalten in: BMC medical education | 2022

von Mohseni, F. | Mohammadi, A. | Mafinejad, M. | +2

8

Inflawell® improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial

enthalten in: Inflammopharmacology | 2022

von Barzin Tond, S. | Balenci, L. | Khajavirad, N. | +16

CommentIn: Inflammopharmacology. 2022 Jun;30(3):1129-1130. - PMID 35316428

9

$ Inflawell^{®} $ improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial

enthalten in: Inflammopharmacology | 2022

von Barzin Tond, S. | Balenci, L. | Khajavirad, N. | +16

10

$ Inflawell^{®} $ improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial

enthalten in: Inflammopharmacology | 2022

von Barzin Tond, S. | Balenci, L. | Khajavirad, N. | +16